TYP 8.11% 2.0¢ tryptamine therapeutics limited

Codiak ($800mil market capitalisation), page-2

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    $EX1 is ludicrously undervalued if Codiak is anywhere near true value.

    That's without the mountain of news that looks to be coming from the EX1 camp in 2021.

    My only interest now is how long it takes for the market to twig and how high it goes.

    There are only two listed pure exosome plays in the world.

    We didn't really know how the market would value the research ,technology and future developments because in market terms it is a new medicine , even though off market an extensive amount of research had been done.

    Now we know.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(8.11%)
Mkt cap ! $20.69M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $52.72K 2.684M

Buyers (Bids)

No. Vol. Price($)
2 547215 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 71269 1
View Market Depth
Last trade - 12.58pm 10/07/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.